Publication:
Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep
Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep
No Thumbnail Available
Date
2013
Authors
Ortiz, P
Scarcella, S
Cerna, C
Rosales, C
Cabrera, M
Guzman, M
Lamenza, P
Solana, H
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier B.V.
Research Projects
Organizational Units
Journal Issue
Abstract
Fasciolosis caused by Fasciola hepatica, is the most prevalent parasitic disease in dairy cattle from the northern region of Cajamarca, Peru. The control of this parasite is based on the use of Triclabendazole (TCBZ), a drug that has been used for more than fifteen years in this area. Recent studies, however, have reported a lack of clinical efficacy after treating dairy cattle. This research was aimed to determine the efficacy of TCBZ in a clinical trial.
Description
The authors acknowledge CONCYTEC from Peru for the financial support.
Keywords
Triclabendazole,
Fasciola hepatica,
Drug resistance,
Cajamarca